LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 202 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $7,162 | -14.8% | 85,000 | -26.1% | 2.86% | -3.9% |
| Q1 2024 | $8,407 | +2.3% | 115,000 | 0.0% | 2.97% | -5.3% |
| Q4 2023 | $8,214 | +19.2% | 115,000 | 0.0% | 3.14% | +19.3% |
| Q3 2023 | $6,891 | -16.9% | 115,000 | 0.0% | 2.63% | -20.3% |
| Q2 2023 | $8,292 | -2.0% | 115,000 | 0.0% | 3.30% | -0.7% |
| Q1 2023 | $8,459 | +10.1% | 115,000 | 0.0% | 3.32% | +14.5% |
| Q4 2022 | $7,682 | -99.9% | 115,000 | 0.0% | 2.90% | -30.4% |
| Q3 2022 | $9,902,000 | -3.5% | 115,000 | 0.0% | 4.17% | -3.3% |
| Q2 2022 | $10,261,000 | -20.7% | 115,000 | 0.0% | 4.31% | +4.6% |
| Q1 2022 | $12,937,000 | +11.7% | 115,000 | +53.3% | 4.12% | +4.8% |
| Q4 2021 | $11,585,000 | – | 75,000 | – | 3.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
| Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
| VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
| Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
| Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
| Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
| Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
| Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |